412 results on '"La Nasa G"'
Search Results
2. Autoimmune liver disease triggered by SARS-CoV-2: a case report and review of the literature.
3. Safety and efficacy of caplacizumab retreatment in a real-life monocentric cohort of patients with immune-mediated thrombotic thrombocytopenic purpura
4. L1CAM EXPRESSION IDENTIFIES DIFFERENT COLORECTAL TUMOR SUBGROUPS
5. Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes
6. Safe fluoroquinolones prophylaxis in blood cancer patients with chemotherapy‐induced neutropenia and Glucose‐6‐Phosphate‐Dehydrogenase deficiency
7. The human carotid atherosclerotic plaque: an observational review of histological scoring systems.
8. Clinical course and features of persistent polyclonal B-cell lymphocytosis with BCL-6 amplification during pregnancy.
9. Balance between the stem cell marker CD44 and CDX2 expression in colorectal cancer
10. Three is better than two: humoral response in allogeneic HSCT after the third BNT162b2 SARS-CoV-2 mRNA vaccine.
11. Chronic graft vs. host disease and hypogammaglobulinemia predict a lower immunological response to the BNT162b2 mRNA COVID-19 vaccine after allogeneic hematopoietic stem cell transplantation.
12. Thyroid autoimmunity and hypothyroidism are associated with deep molecular response in patients with chronic myeloid leukemia on tyrosine kinase inhibitors
13. Return to normal life after hematopoietic stem cell transplantation for thalassemia: a study of patients transplanted from matched sibling donors
14. Expression of L1 Cell Adhesion Molecule (L1CAM) in extracellular vesicles in the human spinal cord during development.
15. BAT2 and BAT3 polymorphisms as novel genetic risk factors for rejection after HLA-related SCT
16. Reactivation of hepatitis B virus infection following ruxolitinib treatment in a patient with myelofibrosis
17. VERY LONG-TERM RESULTS OF ALL-TRANS RETINOIC ACID AND ARSENIC TRIOXIDE IN NON-HIGH RISK ACUTE PROMYELOCYTIC LEUKEMIA: LATEST UPDATE OF THE ITALIAN-GERMAN APL0406 RANDOMIZED TRIAL
18. Interindividual variability in L1CAM expression in the human kidney during development: are there implications for fetal programming of kidney diseases presenting in adulthood?
19. Strong ACE-2 expression in the choroidal vessels: do high choroid plexuses serve as a gateway for SARS-CoV-2 infection on the human brain?
20. Decision-making in adult thalassemia patients undergoing unrelated bone marrow transplantation: quality of life, communication and ethical issues
21. Unrelated donor stem cell transplantation in adult patients with thalassemia
22. Quality of life in thalassemia patients twenty years after transplantation: long term outcome and return to normal lifestyle: O370
23. Hematopoietic stem cell transplantation for multiple sclerosis: A retrospective multicenter study
24. Ultrastructural findings of lung injury due to Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT) following COVID-19 vaccination: a scanning electron microscopic study.
25. Inhibitory KIR 2DL5 influences the outcome of autologous haematopoietic stem cell transplantation for multiple myeloma: P892
26. Health-related quality of life assessment during high-dose chemotherapy and stem cell transplantation in patients with haematologic malignancies: P660
27. The presence of activating killer immunoglobulin-like receptors on donor natural killer cells is critical to the successful outcome of unrelated donor allogeneic haematopoietic stem cell transplantation for thalassaemia: P442
28. The role of killer immunoglobulin-like receptor haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia
29. In vitro ovine articular chondrocyte proliferation: experiments and modelling
30. Lenalidomide treatment of myelodysplastic syndromes with chromosome 5q deletion: Results from the National Registry of the Italian Drug Agency
31. Experimental analysis and modelling of in vitro proliferation of mesenchymal stem cells
32. Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major: an update: O414
33. High incidence of improvement after autotologous HSCT in relapsing-remitting phase of multiple sclerosis: O295
34. Fetal programming of atherosclerosis: may the barker hypothesis explain the susceptibility of a subset of patients to develop stroke or cardiac infarct?
35. Aortic vulnerability to COVID-19: is the microvasculature of vasa vasorum a key factor? A case report and a review of the literature.
36. Gynecomastia in a male after dasatinib treatment for chronic myeloid leukemia
37. Donor-recipient HLA class I ligands and KIR-haplotype A are associated with severe acute graft-versus-host disease in unrelated haematopoietic stem cell transplantation for beta-thalassaemia
38. Communication biases during informed consent for unrelated bone marrow transplantation in adult thalassaemia patients
39. Autologous HSCT for severe progressive multiple sclerosis in the Italian prospective, multicentre GITMO-Neuro trial: long-term follow-up
40. Two new cases of acute promyelocytic leukemia following mitoxantrone treatment in patients with multiple sclerosis
41. Unrelated bone marrow transplantation with reduced - intensity regimen in high-risk patients for age or disease: a prospective GITMO study
42. Vaccine-induced severe thrombotic thrombocytopenia following COVID-19 vaccination: a report of an autoptic case and review of the literature.
43. Immunohistochemical findings in the lungs of COVID-19 subjects: evidence of surfactant dysregulation.
44. Low transplant related mortality following allogeneic peripheral stem cell transplantation with reduced-intensity conditioning regimen in myelodysplastic syndrome and acute myeloid leukaemia from MDS: a prospective study from GITMO
45. Immunoablation followed by stem cell rescue in refractory multiple sclerosis: long-term follow-up of MRI and quality of life
46. Erratum: BAT2 and BAT3 polymorphisms as novel genetic risk factors for rejection after HLA-related SCT
47. Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study
48. PB1999 SECOND MALIGNANCIES IN LYMPHOMA SURVIVORS: A SINGLE CENTER EXPERIENCE
49. PB1894 INFECTIOUS RISK AND HYPOGAMMAGLOBULINEMIA IN A MONOCENTRIC REAL LIFE COHORT OF 211 CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS FOLLOWED FOR 25 YEARS
50. Unrelated donor marrow transplantation for chronic myelogenous leukaemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.